IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS.
- DOI
- 10.1097/iae.0000000000004572
- Published
- 2025 Nov 1
- Container
- Retina (Philadelphia, Pa.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/iae.0000000000004572,
title = {IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS.},
author = {Jaffe GJ and Deák G and Gibson K and Khurana RN and Nudleman E and Ogura Y and Schmidt-Erfurth U and Wang T and Westenskow PD and Wong D and Yiu G and Willis JR},
year = {2025},
journal = {Retina (Philadelphia, Pa.)},
doi = {10.1097/iae.0000000000004572},
url = {https://doi.org/10.1097/iae.0000000000004572}
}RIS
TY - JOUR TI - IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS. AU - Jaffe GJ AU - Deák G AU - Gibson K AU - Khurana RN AU - Nudleman E AU - Ogura Y AU - Schmidt-Erfurth U AU - Wang T AU - Westenskow PD AU - Wong D AU - Yiu G AU - Willis JR PY - 2025 JO - Retina (Philadelphia, Pa.) DO - 10.1097/iae.0000000000004572 UR - https://doi.org/10.1097/iae.0000000000004572 ER -
APA
GJ, J., G, D., K, G., RN, K., E, N., Y, O., U, S., T, W., PD, W., D, W., G, Y., & JR, W. (2025). IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS.. Retina (Philadelphia, Pa.). https://doi.org/10.1097/iae.0000000000004572
Source records
- pubmed · retrieved 2026-09-27T11:28:38.369Z